Today: 17 May 2026
HSBC share price slips again as oil shock keeps UK banks in focus
4 March 2026
1 min read

HSBC share price slips again as oil shock keeps UK banks in focus

London, March 4, 2026, 08:20 GMT — Regular session

HSBC Holdings (HSBA.L) slipped another 1.0% to 1,249.6 pence by 08:20 GMT in early London trading on Wednesday, tacking on more losses after last week’s peak. Shares had wrapped up Tuesday at 1,262.8 pence.

HSBC dropped 5.2% on Tuesday, marking the steepest fall among European banks, as concerns over a drawn-out Middle East conflict and rising oil-driven inflation unsettled traders. “Any ceasefire for now looks like a remote possibility,” Quilter investment strategist Lindsay James said. Reuters

UK bank stocks stumbled in Monday’s global selloff, swept up in the wider risk-off shift as investors moved towards safer ground. HSBC, Barclays, and Lloyds each dropped between 2.5% and 4.2%. Oil prices surged, prompting traders to scale back expectations for imminent Bank of England rate cuts, according to Reuters.

At HSBC, it’s the bigger economic backdrop that counts, not just whatever’s in the news each morning. While higher interest rates may fatten up lending margins for banks, a stubborn energy shock throws a wrench in growth prospects and simultaneously ups the risk on loans.

Sentiment has quickly flipped from wondering “how high can banks go” to focusing on “how quickly can conditions turn.” HSBC remains a heavyweight in both London and European indices, so its shares often magnify the sector’s moves.

Company headlines have tapered off this week. Just last week, HSBC signed off on a fourth interim dividend of $0.45 a share and made it clear: new share buybacks are on hold until its CET1 capital ratio, a key capital yardstick, returns to or tops its target band.

Still, the risk for bank stocks is straightforward. Should oil remain high and inflation pressures build, central banks could have to keep policy tight. That scenario can squeeze borrowers and drive up projected credit losses, even as headline rates appear “good” for margins.

HSBC shares could get their next jolt from outside the earnings columns. Traders are eyeing the Middle East for changes in sentiment, and oil’s path—stabilizing or fanning more volatility—remains a key concern.

Coming up sooner: HSBC’s dividend schedule. Shares go ex-dividend on March 12 for London, Hong Kong and Bermuda holders. New York’s ex-div falls a day later, on March 13. Mark April 30 for the actual payment.

Stock Market Today

  • Dow Appoints Karen S. Carter as First Female CEO; Jim Fitterling to Executive Chair
    May 16, 2026, 9:16 PM EDT. Dow (NYSE: DOW) named Karen S. Carter as CEO, effective July 1, 2026, marking a historic first female leader in its 126-year existence. Carter, 55, promoted from Chief Operating Officer, has over 30 years with the company, overseeing key segments including Packaging and Specialty Plastics. Jim Fitterling, current CEO and Chairman, will shift to Executive Chairman, focusing on strategy and governance. The move concludes a multi-year succession plan by Dow's board. Carter's appointment signals confidence in internal operational leadership rather than an external transformation figure. The transition aims to sustain momentum amid ongoing challenges in global chemical and materials markets, maintaining strategic continuity with Independent Lead Director Richard Davis supporting governance.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 04.03.2026

Snowflake edges closer to the sales floor as EY and Canva roll out “agentic” AI platform
Next Story

Snowflake edges closer to the sales floor as EY and Canva roll out “agentic” AI platform

Go toTop